6 September 2021

Celtarys Research has been one of the finalists of the 2021 RSC Emerging Technologies Competition

The Emerging Technologies Competition is the Royal Society of Chemistry’s annual initiative for early-stage companies and academic entrepreneurs who want to commercialise their technologies to make […]
31 August 2021

Celtarys Research is attending BIOSPAIN 2021

BIOSPAIN, the international meeting focused on biotechnology, is just around the corner and our BD Team will be present in the event. With more than 3,000 […]
31 August 2021

Trends in kinase drug discovery: targets, indications and inhibitor design

Abstract: The FDA approval of imatinib in 2001 was a breakthrough in molecularly targeted cancer therapy and heralded the emergence of kinase inhibitors as a key […]